PTGX
Protagonist Therapeutics Inc
Price:  
41.60 
USD
Volume:  
444,708.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PTGX Probability of Bankruptcy

The Probability of Bankruptcy of Protagonist Therapeutics Inc (PTGX) is 45.95% . This number represents the probability that PTGX will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating PTGX's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

PTGX - ESG ratings

ESG ratings are directly linked to the cost of capital and PTGX's ability to raise funding, both of which can significantly affect the probability of Protagonist Therapeutics Inc going bankrupt.

ESG Score 50.80
Environment Score 19.23
Social Score 91.20
Governance Score 41.95
Returns
Historical Returns (5 day) -1.82%
Historical Returns (MTD) -7.53%
Historical Returns (YTD) 76.62%
Historical Returns (13 week) -9.17%
Historical Returns (26 week) 19.01%
Historical Returns (52 week) 98.92%
Efficiency
Asset Turnover 0.59
Receiveable Turnover
Gross Margin
Operating Margin 46.05%
Pretax Margin 53.45%
Net Margin 52.76%
Return on Asset (ROA) 30.98
Return on Equity (ROE) 34.68
Return on Investments (ROI) 34.68
Price Metrics
Market Cap (M) 2,450.24
Enterprise Value (M)
52 Week High 48.89
52 Week Low 19.06
Beta 1.62
Average Volume (10 day) 0.66
Average Volume (3 month) 0.67
Price / Earnings (P/E) 14.67
Price / Sales (P/S) 7.74
Earnings
EPS 2.68
Revenue CAGR (5 year) 14.17%
Risk
Current Ratio 10.70
Quick Ratio 10.57